We are live on ! Find out more
ACM

Atalaya Capital Management Portfolio holdings

AUM $45M
1-Year Est. Return 3.02%
This Fund
S&P 500
This Quarter Est. Return
-8.91%
1 Year Est. Return
+3.02%
3 Year Est. Return
+7.46%
5 Year Est. Return
10 Year Est. Return
AUM
$89.8M
AUM Growth
-$116M
Cap. Flow
-$97M
Cap. Flow %
-108.03%
Top 10 Hldgs %
80%
Holding
184
New
12
Increased
2
Reduced
6
Closed
37
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SATX
26
DELISTED
SatixFy Communications
SATX
$398K 0.44%
750,763
-1,000,000
-57% -$473K
SLND icon
27
Southland Holdings
SLND
$31.4M
$321K 0.36%
+52,941
New +$391K
DRTS icon
28
Alpha Tau Medical
DRTS
$1.19B
$279K 0.31%
73,742
LZM.WS icon
29
Lifezone Metals Ltd Warrants
LZM.WS
$29.5M
$236K 0.26%
+200,000
New +$173K
NIOBW
30
NioCorp Developments Ltd Warrant
NIOBW
$79.3M
$207K 0.23%
350,528
ACHR.WS icon
31
Archer Aviation Redeemable Warrants
ACHR.WS
$24.7M
$188K 0.21%
150,042
-127,074
-46% -$183K
LVWR.WS icon
32
LiveWire Group Warrants
LVWR.WS
$5.09M
$175K 0.19%
500,000
ACAQ.WS
33
DELISTED
Athena Consumer Acquisition Corp. Redeemable warrants included as part of the units, each whole warrant exercisable for one share of Class A common stock for $11.50 per share
ACAQ.WS
$144K 0.16%
400,000
RBT
34
DELISTED
Rubicon Technologies, Inc.
RBT
$130K 0.14%
62,500
HWELW
35
DELISTED
Healthwell Acquisition Corp. I Warrant
HWELW
$126K 0.14%
738,840
PEGRW
36
DELISTED
Project Energy Reimagined Acquisition Corp. Warrant
PEGRW
$119K 0.13%
989,998
TCOA.WS
37
DELISTED
Zalatoris Acquisition Corp. Public warrants, each whole public warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50 per share
TCOA.WS
$115K 0.13%
603,429
LLAP
38
DELISTED
Terran Orbital Corporation
LLAP
$91.3K 0.1%
109,966
SOC.WS
39
DELISTED
Sable Offshore Corp. Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50
SOC.WS
$80K 0.09%
100,000
SWSSW
40
DELISTED
Clean Energy Special Situations Corp. Warrant
SWSSW
$74.3K 0.08%
742,500
DRTSW icon
41
Alpha Tau Medical Warrant
DRTSW
$79.6M
$72.9K 0.08%
280,474
AAC.WS
42
DELISTED
Ares Acquisition Corporation Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
AAC.WS
$69K 0.08%
104,520
USCTW
43
DELISTED
Roth CH Acquisition Co. Warrant
USCTW
$66.5K 0.07%
950,000
CDAQW
44
DELISTED
Compass Digital Acquisition Corp. Warrant
CDAQW
$58.4K 0.07%
265,481
REE
45
DELISTED
REE Automotive
REE
$49.3K 0.05%
10,964
GAQ.WS
46
DELISTED
Generation Asia I Acquisition Limited Redeemable Warrants included as part of the units, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
GAQ.WS
$48.3K 0.05%
804,573
BYNOW
47
DELISTED
byNordic Acquisition Corporation Warrant
BYNOW
$46.5K 0.05%
516,185
FZT.WS
48
DELISTED
FAST Acquisition Corp. II Redeemable warrants, each whole warrant exercisable for one share of Class A common stock, each at an exercise price of $11.50 per share
FZT.WS
$43.3K 0.05%
86,514
LOCC.WS
49
DELISTED
Live Oak Crestview Climate Acquisition Corp. Warrants, exercisable for one share of Class A common stock at an exercise price of $11.50 per share
LOCC.WS
$42.2K 0.05%
527,999
MPRAW
50
DELISTED
Mercato Partners Acquisition Corporation Warrant
MPRAW
$42K 0.05%
200,000

Similar funds

Atalaya Capital Management's Q3 2023 Portfolio in Review

As of Q3 2023, Atalaya Capital Management held 184 positions worth $89.8M, down 56% from $206M the previous quarter. Its ten largest holdings account for 80% of the portfolio.

Atalaya Capital Management withdrew a net $97M in Q3 2023, closing 37 positions and reducing 6 holdings. Its most notable exit was Project Energy Reimagined Acquisition Corp. Class A Ordinary Share, an estimated $20.5M position sold in full.

By sector, the portfolio is most concentrated in Financials at 39% of assets, down from 72% a quarter earlier, followed by Healthcare and Industrials.

Against the trend, Atalaya Capital Management opened a new position in AEON Biopharma worth $19.8M.

  • Atalaya Capital Management's largest Q3 2023 buy was AEON Biopharma: 51,042 shares worth $19.8M.
  • Atalaya Capital Management added most to Conduent in Q3 2023, an estimated $1.42M increase.
  • Atalaya Capital Management's biggest Q3 2023 reduction was Plum Acquisition Corp. III Class A Ordinary Shares, cutting an estimated $10.5M.
  • Atalaya Capital Management fully exited Project Energy Reimagined Acquisition Corp. Class A Ordinary Share in Q3 2023, selling an estimated $20.5M.
  • Atalaya Capital Management's ten largest holdings make up 80% of its $89.8M portfolio in Q3 2023.
  • Atalaya Capital Management opened 12 new positions and closed 37 in Q3 2023.
  • Atalaya Capital Management's portfolio value fell 56% quarter-over-quarter to $89.8M.

Based on Atalaya Capital Management's 13F filing for Q3 2023, filed 6 Nov 2023.